This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SOX10 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SOX10 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~49.9 kDa | |
| Observed band | 60-65 kDa | |
| Gel | 10–12% | |
| Positive control | Caudate+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-induced mobility shift | |
| Regulation | Kras signaling dn | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for SOX10 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human SH-SY5Y , Lane 2: human U251 , Lane 3: human U2OS , Lane 4: human U87 , Lane 5: rat brain , Lane 6: rat C6 , Lane 7: mouse brain , Lane 8: mouse Neuro-2a . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-SOX10 antigen affinity purified polyclonal antibody (Catalog # A00758-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for SOX10 at approximately 60 kDa. The expected band size for SOX10 is at 50 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 60 kDa |
SOX10 has a 49.9 kDa calculated backbone but runs at 60-65 kDa on Western blot, an anomalous migration shift typical of basic DNA-binding transcription factors.
| Single band around 60-65 kDa | the native SOX10 signal, running well above the 49.9 kDa calculated mass due to anomalous SDS-PAGE migration typical of this basic DNA-binding transcription factor rather than a modification |
| Faint band near 50 kDa | position matching the unmodified calculated mass, sometimes seen when the protein migrates closer to its true mass rather than showing the usual anomalous shift |
| Two closely spaced bands | reflects expression of both annotated splice isoforms (1 and 2) rather than degradation or nonspecific binding |
| Signal detected across nuclear and cytoplasmic lysate fractions | consistent with SOX10 shuttling between cytoplasm, nucleus, and the mitochondrial outer membrane rather than being confined to one compartment |
| No shift in band position between reducing and non-reducing sample buffer | expected because SOX10 has no annotated disulfide bonds or disulfide-linked dimer formation |
| Clean single band with no high-molecular-weight smear | expected because SOX10 has no annotated glycosylation sites that would create heterogeneous glycoform smearing |
| Predicted mass from UniProt sequence | 466 aa backbone calculates to 49.9 kDa, the theoretical baseline before any migration effects |
| DNA-binding transcription factor domain | the basic, charged DNA-binding/transcriptional regulator domain binds SDS atypically, causing anomalous slower migration and an apparent size well above the calculated mass |
| Serine-24 phosphorylation | adds only a small amount of mass and contributes at most marginally to any upward shift, not the full gap seen on blot |
| Alternative splicing, isoforms 1 and 2 | the isoform expressed in a given sample can shift which band position or relative intensity predominates |
| Absence of glycosylation and disulfide bonding | rules out glycosylation-driven smearing and disulfide-linked dimerization as causes of the observed band position |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | anomalous SDS-PAGE migration of the basic DNA-binding domain, not degradation or error | compare against the established 60-65 kDa reference band and confirm with a known-positive lysate before troubleshooting further |
| Multiple bands | co-expression of the two annotated splice isoforms | check which isoform is expressed in the tissue or cell line and whether the antibody epitope is common to both |
| Band lower than expected | proteolytic degradation during lysate preparation, since no cleavage event is annotated to naturally produce a smaller form | add protease inhibitors, keep lysates cold throughout, and use fresh rather than freeze-thawed sample |
| Weak or no signal | SOX10 expression is lineage-restricted to neural crest derivatives such as melanocytes, Schwann cells, and oligodendrocytes | use a characterized positive-control lysate from a relevant lineage and increase total protein loaded |
| Broad smear instead of sharp band | aggregation or incomplete denaturation of this nuclear DNA-binding protein rather than glycosylation, since none is annotated | ensure complete lysis and denaturation with SDS sample buffer and adequate heating, and avoid overloading the gel |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | High | Protein (IHC) | HPA → |
| Hippocampus | glial cells | High | Protein (IHC) | HPA → |
| Salivary gland | glandular cells | High | Protein (IHC) | HPA → |
| Cerebellum | GLUC cells - nucleus | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | glial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SOX10, answered from its protein features.
BosterBio's SOX10 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-SOX10 antibodies are top-performing, extensively cited reagents rigorously validated by Western blot and cross-checked against negative-control tissues and orthogonal detection methods, giving confidence in specific, reproducible SOX10 detection for your experiments.
Which to pick: Both A00758-1 and A00758-3 have a real Western blot validation image confirming SOX10 detection, so either is a solid choice; no other distinguishing details are listed for these two SKUs, so pick either, or run both in parallel if you want extra cross-checking confidence.